Cell assembly-mediated delivery of checkpoint inhibitors for cancer immunotherapy
US12161720B2 · kind B2 · utility
0Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2019 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Jan 31, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are therapeutic agent delivery vehicle comprising a modified platelet comprising a therapeutic agent cargo and a targeting moiety and methods for treating cancer comprising administering the same to a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.